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UNIT 1.2Enzymatic Synthesis of M1G-Deoxyribose
M1G-deoxyribose (M1G-dR, 1,N2-pyrimido[1,2-α]purin-10(3H)-one, or pyrimidopuri-
none; see structure in Fig. 1.2.2, below) is an endogenous exocyclic DNA adduct formed
by the reaction of the dicarbonyl compound malondialdehyde (MDA) with a deoxy-
guanosine residue in DNA. M1G-dR is an intermediate in the synthesis of a class of
modified oligodeoxyribonucleotides that are used to study the mutagenicity and repair of
M1G.
This unit presents two methods for synthesizing M1G-dR using enzymatic coupling. The
Basic Protocol describes a procedure for coupling the nucleobase to deoxyribose, in a
reaction mediated by the enzyme nucleoside 2′-deoxyribosyltransferase, followed by
preparation of the modified base (see Fig. 1.2.1A). Preparation of the enzyme is described
in the Support Protocol. The Alternate Protocol uses two commercially available en-
zymes, purine nucleoside phosphorylase and thymidine phosphorylase (see Fig. 1.2.1B).
Although the enzyme preparation step is avoided, additional purification steps are
required that increase the time needed to complete the synthesis and decrease the yield
(see Commentary).
NOTE: Use deionized, distilled water in all recipes and protocol steps.
BASIC
PROTOCOL
ENZYMATIC COUPLING USING NUCLEOSIDE
2′-DEOXYRIBOSYLTRANSFERASE
Nucleoside 2′-deoxyribosyltransferase (trans-N-deoxyribosylase or nucleo-
side:purine(pyrimidine) deoxyribosyltransferase; E.C. 2.4.2.6) catalyzes the transfer of
the deoxyribosyl moiety from a deoxyribonucleoside to any other  nucleoside base (see
Fig. 1.2.1A). This enzyme is found exclusively in Lactobacilli and related microorgan-
isms that require deoxynucleosides for growth (Carson and Wasson, 1988). The enzyme’s
broad specificity makes it a useful tool for synthesizing modified deoxyribonucleotides.
This protocol describes the use of this enzyme (see Support Protocol for preparation) to
transfer a deoxyriboside from 2′-deoxycytidine to M1G and produce M1G-dR. The two
synthesis steps can be carried out in a single flask, which decreases the time needed to
purify M1G-dR and significantly increases the yield of the reaction.
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Figure 1.2.1 Enzymatic coupling reactions. (A) Reaction catalyzed by nucleoside 2′-deoxyribo-
syltransferase (Basic Protocol). (B) Reaction catalysed by thymidine phosphorylase and purine
nucleoside phosphorylase (Alternate Protocol).
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Materials
Guanine hydrochloride (Sigma)
1 N HCl
Tetraethoxypropane (Aldrich)
Methanol (MeOH; Aldrich)
Potassium carbonate (Aldrich)
Nanopure water (water purified using Nanopure system from
Barnstead/Thermolyne)
MES (2-[N-morpholino]ethanesulfonic acid; Sigma)
2′-Deoxycytidine (dC; Sigma)
1 N NaOH
Nucleoside 2′-deoxyribosyltransferase (transferase; see Support Protocol)
Dichloromethane (CH2Cl2; Fisher)
250-mL round-bottom flask
Oil bath, 70°C
Magnetic stir plate and stir bar
Ice bath
pH indicator strips
Büchner funnel
Whatman No. 1 filter paper
Shaking incubator, 37°C
Silica-gel thin-layer chromatography (TLC) plates
Lyophilizer
Silica gel (60 to 100 mesh; Fisher)
8 × 50–cm chromatography column
Prepare modified base
1. In a 250-mL round-bottom flask, dissolve 1 g (5.3 mmol) guanine hydrochloride in
100 mL of 1 N HCl that has been heated to 70°C using an oil bath. Stir on a magnetic
stir plate until dissolved.
The dissolution can take from 30 min to 1 hr.
2. Mix 1.3 mL (5.86 mmol) tetraethoxypropane with 1.25 mL methanol. Add this
dropwise to the solution from step 1.
Slow addition of tetraethoxypropane favors the formation of the modified base and avoids
the polymerization of MDA.
3. Let the reaction mixture stir for 30 min on a magnetic stir plate, then cool to 0°C in
an ice bath.
Cooling moderates the neutralization reaction to follow.
4. Neutralize by slowly adding potassium carbonate to pH 6, verifying the pH using pH
indicator strips. Take special care when approaching the desired pH.
5. Remove unreacted guanine by filtering through Whatman no. 1 filter paper on a
Büchner funnel under vacuum. Wash the precipitate twice with 20 mL of Nanopure
water.
The filtrate contains the modified base. The yield of the reaction is estimated at 30%.
6. Add MES to a final concentration of 0.5 M.
MES is used to buffer the enzymatic reaction.
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7. Add 1.2 g (5.3 mmol) 2′-deoxycytidine.
8. Equilibrate the solution to pH 6.0 with 1 N HCl or 1 N NaOH.
Perform enzymatic coupling
9. Add an appropriate amount of nucleoside 2′-deoxyribosyltransferase solution and
incubate overnight at 37°C with shaking.
Each enzymatic preparation has its own concentration and activity, which must be tested
empirically by assaying the preparation’s ability to convert a small quantity of M1G to
M1GdR to estimate the amount to use for the full-scale reaction.
10. Check the progress of the reaction by TLC on silica-gel plates using 9:1 (v/v)
CH2Cl2/MeOH as the mobile phase.
Add 50 L methanol to 50 L of reaction mix and spot on TLC plate using a capillary tube.
If the reaction is not complete, add more enzyme and dC, but not more than one-fifth the
amount used at the start of the reaction, and incubate an additional 6 to 12 hours.
11. Once the reaction is complete, lyophilize the reaction mixture to dryness.
12. Purify the crude product on a silica-gel column using 9:1 (v/v) CH2Cl2/MeOH for
equilibration and elution. Elute by gravity and collect 50-mL fractions.
The lyophilized reaction mixture may be added directly to the top of the packed column.
13. Confirm the purity of the product by 1H NMR. Store the product under nitrogen at
–20°C. Under these conditions, it is stable for several years.
A typical spectrum is presented in Figure 1.2.2. The estimated yield is 10% to 15%.
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Figure 1.2.2 1H NMR spectrum of M1-GdR in D2O.
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SUPPORT
PROTOCOL
PREPARATION OF NUCLEOSIDE 2′-DEOXYRIBOSYLTRANSFERASE
Nucleoside 2′-deoxyribosyltransferase was first isolated by McNutt (1952). Partial puri-
fication of the enzyme from Lactobacillus leichmannii has been described by Beck and
Levin (1963), and its complete purification and crystallization by Uerkvitz (1971). This
protocol is based upon the latter method. The partial purification described here is
sufficient for obtaining enzyme to be used in the Basic Protocol.
Materials
Lactobacillus broth AOAC (see recipe)
Lactobacillus helveticus culture
0.15 M NaCl (4°C)
50 mM potassium phosphate buffers, pH 6.0 and 6.9 (see APPENDIX 2A; dilute with
Nanopure water to desired molarity)
50 mM potassium phosphate, pH 5.1, containing 10 g/L NaCl
250-mL Erlenmeyer flask
Centrifuge and rotors (e.g., Sorvall GS-3 and SS-34)
Microtip sonicator (Virsonic 100)
BCA Protein Assay (Pierce; optional) or equivalent
Purify the enzyme
1. Using aseptic technique, place 25 mL of Lactobacillus broth in an Erlenmeyer flask.
Add a loopful of Lactobacillus helveticus commercial stock and incubate overnight
at 37°C without shaking.
2. Transfer the 25-mL culture into 1000 mL of fresh Lactobacillus broth. Grow 18 hr
at 37°C without shaking.
3. Cool to 4°C and divide into centrifuge tubes. Centrifuge the tubes 10 min at 7000 ×
g (6500 rpm in a GS-3 rotor), 4°C.
4. Resuspend pellets in 100 mL cold 0.15 M NaCl and centrifuge again as in step 3.
Repeat.
5. Suspend cell pellets in a total of 20 mL of 50 mM potassium phosphate, pH 6.0.
6. Sonicate 10 times for 1 min each time with a Virsonic 100 microtip sonicator at a
setting of 4 to 5.
7. Centrifuge 30 min at 28,000 × g (15,000 rpm in an SS-34 rotor), 4°C. Save the
supernatant.
8. Wash the pellets twice by resuspending in a minimal volume of 0.15 M NaCl and
centrifuging as in step 7. Save the supernatants.
9. Combine the supernatants from the previous two steps, and dialyze overnight against
4 L of 50 mM potassium phosphate, pH 5.1, containing 10 g/L NaCl.
10. Heat 10 min at 55°C, then immediately place on ice.
The heating denatures all heat-sensitive proteins that are present in the extract, thereby
enriching for transferase, which is not heat sensitive.
11. Centrifuge again as in step 7.
12. Collect the supernatant and dialyze overnight in 50 mM potassium phosphate, pH
6.9.
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To quantify the amount of total protein purified, the BCA Protein Assay (Pierce) can be
used.
For the purpose of this experiment, this level of purification is sufficient. Store the protein
in aliquots at −20°C or proceed to coupling experiments (see Basic Protocol).
Assay the enzyme
13. Prepare five 5-mL aliquots of filtrate containing M1G (see Basic Protocol, step 8).
14. Add to the filtrate 50, 100, 150, 200, and 250 µL of supernatant containing the enzyme
(from step 12).
15. Incubate overnight at 37°C with shaking.
16. Spot 10 µL of each reaction mixture three times on a TLC plate using 9:1 (v/v)
CH2Cl2/MeOH as the mobile phase. Determine presence of M1G-dR.
ALTERNATE
PROTOCOL
ENZYMATIC COUPLING USING PURINE NUCLEOSIDE
PHOSPHORYLASE AND THYMIDINE PHOSPHORYLASE
Purine nucleoside phosphorylase (PNPase; E.C. 2.4.2.1) catalyzes the displacement of
phosphate from deoxyribose-1-phosphate on purines and purine analogs. The stereo-
chemistry of purine attachment produces the naturally occurring β-isomers. Although
ribose-1-phosphate is commercially available, it may be more conveniently and
cost-effectively generated in situ by thymidine phosphorylase (TPase; E.C. 2.4.2.4)–cata-
lyzed phosphorolysis of thymidine (see Fig. 1.2.1).
This Alternate Protocol can be used to avoid the transferase preparation required for the
Basic Protocol. First the modified base is synthesized and purified, then the enzymatic
coupling is initiated, and finally the product is separated on a medium-performance liquid
chromatography (MPLC) column. Due to the instability of M1G, only 2% to 5% of product
is recovered, regardless of the yields achieved in the transribosylation step.
Additional Materials (also see Basic Protocol)
Thymidine (e.g., Sigma)
Purine nucleoside phosphorylase (PNPase; Sigma)
Thymidine phosphorylase (TPase; Sigma)
20 mM potassium phosphate, pH 7.3 (APPENDIX 2A)
MPLC buffer: 20% methanol in water
UV lamp (254 and 365 nm)
mPLC column (Baker C18-40 µm, 30 × 500 mm)
Prepare modified base
1. Prepare modified base (see Basic Protocol, steps 1 to 5).
2. Concentrate the filtrate under vacuum.
3. Prepare a slurry of the residue with ∼10 g silica gel.
4. Purify by chromatography on a silica-gel column using 9:1 (v/v) CH2Cl2/MeOH for
equilibration and elution.
5. Collect and combine the fractions containing M1G as determined by UV fluores-
cence.
M1G base is fluorescent under the long-wavelength (365 nm) of the UV lamp.
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6. Evaporate under vacuum and store under nitrogen at –20°C.
7. Verify the purity of M1G base by 1H NMR.
The estimated yield is 2% to 5%.
Perform enzymatic coupling
8. Dissolve 37 mg (0.2 mmol) M1G base and 73 mg (0.6 mmol) thymidine in 200 mL
of 20 mM potassium phosphate buffer. Adjust the pH to 7.3 with 1 N HCl or 1 N
NaOH.
9. Add 20 U TPase and 30 U PNPase.
10. Incubate the solution 18 hr at 37° to 39°C with shaking.
Verify the completion of the enzymatic coupling by thin-layer chromatography (see Basic
Protocol, step 10). If the reaction is not complete, continue the purification without further
incubation.
11. Concentrate the reaction under vacuum.
This and all subsequent vacuum steps may be performed using a side-arm flask with water
aspiration.
12. Prepare a slurry of the residue with ∼5 g silica gel.
13. Purify by chromatography on a silica-gel column using 9:1 (v/v) CH2Cl2/MeOH for
equilibration and elution. Elute by gravity and collect 50-mL fractions.
14. Collect the fractions containing M1G-dR as determined by yellow fluorescence at
365 nm.
M1G and M1G-dR have different elution times.
15. Evaporate to dryness under vacuum. Redissolve two aliquots in 2 mL MPLC buffer
each.
16. Purify by MPLC on a Baker C18 40 µm, 30 × 500–mm column, eluting with 20%
methanol in water (isocratic) at a flow rate of 3 mL/min.
This second column is necessary to separate thymidine from M1G-dR.
17. Collect the fluorescent fractions and evaporate to dryness under vacuum.
18. Verify the purity of the product by 1H NMR.
A typical spectrum is presented in Figure 1.2.2 (see Basic Protocol). The estimated yield
is 50% to 60%.
REAGENTS AND SOLUTIONS
Use Nanopure water (water purified using Nanopure system from Barnstead/Thermolyne) where
indicated, and deionized, distilled water in all other recipes and protocol steps. For common stock
solutions, see APPENDIX 2A; for suppliers, see SUPPLIERS APPENDIX.
Lactobacillus broth AOAC
Mix 38 g of Lactobacillus broth AOAC (Difco) into 1000 mL Nanopure water. Heat
to boiling for 2 min. Autoclave 30 min and allow to cool to room temperature.
Prepare fresh for each run.
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COMMENTARY
Background Information
Adducts formed between electrophiles and
nucleic acid bases are believed to play a key
role in chemically induced mutations and can-
cer (Singer and Grunnenberger, 1983). Chemi-
cal synthesis of deoxynucleoside adducts pro-
vides not only authentic standards for compari-
son to biologically derived materials but also
reagents for the synthesis of adducted nucleo-
tides (Basu and Essigmann, 1988). The prepa-
ration of certain classes of deoxynucleoside
adducts is problematic because of the instabil-
ity of the intermediates under the conditions
used for synthetic manipulations (e.g., the acid
lability of purine deoxyribosides). Synthetic
approaches to preparing sensitive deoxynu-
cleosides include coupling of adducted bases
to activated deoxyribose derivatives (Srivasta
et al., 1988) and attachment of deoxyribose
moieties to modified bases (Garner and
Ramakanth, 1988). However, there are inherent
difficulties in controlling both the regiochem-
istry (e.g., to achieve attack at the N7 versus N9
atom of a purine) and the stereoselectivity (e.g.,
an SN2 attack on a sugar isomer is needed to
generate the desired linkage). Chemical synthe-
sis increases the difficulty of obtaining the
correct regioselectivity, whereas enzymatic
coupling on nonmodified bases generates only
one regioselective isomer.
Enzymatic coupling of purine or pyrimidine
analogs to deoxyribose has been used to syn-
thesize a number of compounds, including iso-
topically substituted deoxynucleosides, antitu-
mor agents, and biological active molecules
(Holy and Votruba, 1987; Krenitsky et al., 1981,
1986; Muller et al., 1996). When PNPase and
TPase are used on M1G (see Alternate Proto-
col), N9 linkage is shown to be preferred over
N7. With the use of transferase (see Basic
Protocol), complete regioselectivity (for the N9
isomer only) is obtained.
Critical Parameters
Since the pyrimidopurinone M1G-dR syn-
thesized in these procedures is base labile, the
pH must stay below 7.5 for all protocols. M1G
base is even less stable than M1G-dR.
The Basic Protocol does not require purifi-
cation of the modified base; the transferase can
be added to the crude mixture. The desired
nucleoside can be purified by simple column
chromatography. This strategy not only short-
ens the time required for the synthesis, but also
significantly improves the yield. In comparison
the Alternate Protocol, which uses a combina-
tion of two commercially available enzymes, is
more demanding in terms of time and purifica-
tion. M1G base must be purified; moreover,
when the crude mixture is reacted with the
combination of PNPase and TPase, transribo-
sylation is inefficient. Also, due to the close
polarity of thymidine and M1G-dR (in a variety
of solvents system used), a combination re-
versed-phase and straight-phase column must
be employed to obtain pure material.
The transferase used in the Basic Protocol
and prepared in the Support Protocol has a
higher selectivity and produces only the N9
isomer. The two-enzyme method of the Alter-
nate Protocol produces a mixture of N7 and N9,
increasing the difficulty of purification. Once
a stock solution of transferase is prepared, the
Basic Protocol is much easier to perform, less
time-consuming, and gives better yields.
Anticipated Results
The two protocols described in this unit
allow preparation of the desired modified nu-
cleoside in good yields. The Basic Protocol
should give yields between 10% and 15% and
the Alternate Protocol gives between 2% and
5%. Figure 1.2.2 shows the 1H NMR spectrum
of M1G-dR.
Time Considerations
Preparation of transferase (see Support Pro-
tocol) may take 3 to 4 days. The one-step
condensation procedure using transferase (see
Basic Protocol), from the synthesis of the modi-
fied base to the purification of the nucleoside,
should take 24 hr with lyophylization. The
alternative method using commercial phospho-
rylases (see Alternate Protocol) should take 2
or 3 days.
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